•  
  •  
  •  
  •  

2022-08-19 05:10:20

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Syrma SGS Technology IPO subscribed 32.61 times on the final day
  • NHPC signs MoU with Investment Board Nepal, Govt. of Nepal
  • Knowledge Marine & Engineering Works Ltd acquires new vessel
  • MIL's PAT Q1 FY 23 up 96 pc, plans multifold expansion in Africa
  • Seacoast Shipping Services Ltd board approves 1:1 rights issue

Keywords Selected:  SunPharmaceuticalIndustries

Stock Report

  • Sun Pharmaceutical Industries Ltd Update on US FDA Inspection at Mohali Facility
  • Sun Pharmaceutical Industries Ltd receives OAI from USFDA for Halol facility
  • Sun Pharma Chairman, Israel Makov to retire on completion of term
  • Sun Pharmaceutical Industries Ltd Q1 FY2023 consolidated PAT rises to Rs. 2060.88 crores
  • Sun Pharma and Cosmo Announce Territory Expansion of License and Supply Agreements for WINLEVI®
  • Sun Pharma Acquires Uractiv™ Portfolio from Fiterman Pharma in Romania
  • Sun Pharma to launch Brillo®, a first-in-class oral lipid-lowering drug in India
  • Sun Pharma announces US FDA Approval for Generic Mesalamine Extended Release Capsules
  • Sun Pharmaceutical Industries gets 10 observations from US FDA for Halol facility
  • Sun Pharma to introduce its version of Vortioxetine in India under an exclusive patent license from Lundbeck
  • Sun Pharma Presents Phase 3 Data for WINLEVI® (clascoterone) cream 1% for the Topical Treatment of Acne Vulgaris at the AAD Annual Meeting
  • Taro to acquire Alchemee from Galderma
  • Sun Pharmaceutical Industries Ltd declares interim dividend of Rs. 7
  • Sun Pharma Q3FY22 consolidated profit up at Rs. 2058.8 crores
  • Sun Pharma launches solution for dry eye treatment with NCELL™ technology in Canada
  • Sun Pharma receives DCGI approval for Molxvir® in India
  • Sun Pharma announces US FDA Approval for Generic Amphotericin B Liposome Injection
  • Sun Pharma arm DUSA to get $22.5 mn from Biofrontera for settlement of litigation
  • Sun Pharma geared to introduce Molnupiravir, licensed from MSD and Ridgeback, under the brand name Molxvir® in India
  • Sun Pharma announces availability of WINLEVI® (clascoterone) cream 1% in the U.S. for Topical Treatment of Acne Vulgaris
  • Sun Pharmaceutical Industries Ltd posts jump in Q2FY22 consolidated net profit to Rs. 2088.73 crore
  • Sun Pharma's PrILUMYA™ now available to help Canadians living with moderate-tosevere plaque psoriasis

Latest Post

  • Syrma SGS Technology IPO subscribed 32.61 times on the final day
  • NHPC signs MoU with Investment Board Nepal, Govt. of Nepal
  • Knowledge Marine & Engineering Works Ltd acquires new vessel
  • MIL's PAT Q1 FY 23 up 96 pc, plans multifold expansion in Africa
  • Seacoast Shipping Services Ltd board approves 1:1 rights issue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
No:AP-172, 2nd Sector, 10th Street, KK Nagar
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-80560-88967
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

Disclaimer Copyright © - 2021